Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/2005
11/03/2005US20050245455 Gonadotropin releasing hormone antagonists in gel-forming concentrations
11/03/2005US20050245442 Androgens conjugated with mammalian proteins; diagnosis or treatment of solid cancer and hematological malignancies; exhibit synergistic action together with a cytoskeleton-acting drug; prostate cancer
11/03/2005US20050244930 IL-21 antagonists
11/03/2005US20050244915 Assays for modulators of asparaginyl hydroxylase
11/03/2005US20050244899 Laminin Receptor 1 Precursor Protein (37LRP) epitope delineated by an Hepatocellular carcinoma specific antibody
11/03/2005US20050244888 Antibodies to human chemokine beta-9
11/03/2005US20050244839 Granulin-epithelin precursor (GEP) overexpression as a target for diagnosis, prognosis and treatment of hepatocellular carcinoma (HCC)
11/03/2005US20050244826 Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen and/or wnt
11/03/2005US20050244812 Kits and methods for detection of apoptotic cells
11/03/2005US20050244523 Topical anti-cancer compositions and methods of use thereof
11/03/2005US20050244494 Controlled releases system containing temozolomide
11/03/2005US20050244432 Expression of an L1 protein or functional protein derivative from two different types of papillomaviruses, and mixing the two; used for the prevention or treatment of a disease related to papillomavirus infection, such as cervical cancer or genital warts
11/03/2005US20050244428 Site-directed mutagenesis; plasmid vectors; Dengue virus
11/03/2005US20050244421 Compositions and methods for modulating immune response
11/03/2005US20050244418 Recombinant tumor specific antibody and use thereof
11/03/2005US20050244417 Using mixture comprising human estrogen specific immunoglobulin and tumor necrosis factor related apoptosis inducing ligand (APO-2L) for use as tool to enhance apoptosis in cancer cells
11/03/2005US20050244415 administering an antibody which recognizes an extracellular domain of signal regulatory protein-beta (SIRP-beta); treatment of infections or cancer
11/03/2005US20050244414 Method to ameliorate osteolysis and metastasis
11/03/2005US20050244412 Method and composition for regulating activity of regulatory T cells
11/03/2005US20050244408 gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules that comprise the human anti-IGF-IR antibodies; colorectal or breast cancer tumor
11/03/2005US20050244405 Antagonist for endothelial growth agents for treatment of edema and for kidney dialysis
11/03/2005US20050244398 Pharmaceutical preparation and method of treatment of human malignancies with arginine deprivation
11/03/2005US20050244392 Probiotic strains, a process for the selection of them, compositions thereof, and their use
11/03/2005US20050244374 Enveloped miroorganism
11/03/2005US20050244350 Composition including a pigment assembly comprising a mica core
11/03/2005DE19910403B4 3-Hydroxy-1,2,3,3a-tetrahydro-benzo[b]cyclopent[e]azepin-4,10(5H,10aH)-dion-Derivate enthaltende Arzneimittel 3-hydroxy-1,2,3,3a-tetrahydro-benzo [b] cyclopent [e] azepine-4,10 (5H, 10AH) -dione derivatives of drugs containing
11/03/2005CA2807787A1 Hmb compositions and uses thereof
11/03/2005CA2564453A1 Peptide inhibitors of metalloproteinase activity
11/03/2005CA2564180A1 Pharmaceutical preparation containing bacterial cell wall skeleton component
11/03/2005CA2563749A1 Coadministration of radiation, efaproxiral sodium, and supplemental oxygen for the treatment of cancer
11/03/2005CA2562377A1 Novel piperidine substituted diaminothiazoles
11/03/2005CA2561691A1 Method of constructing recombinant herpes simplex virus
11/03/2005CA2560042A1 Hmb compositions and uses thereof
11/02/2005EP1591529A2 Human CLTA-8 and uses of CTLA-8-related proteins
11/02/2005EP1591528A2 Method and compositions for delivery and expression of interferon-alpha nucleic acids
11/02/2005EP1591447A1 Phospholipid derivatives and process for the production there
11/02/2005EP1591446A1 Thienopyrimidine compounds and use thereof
11/02/2005EP1591437A2 Interleukin-1 and tumor necrosis factor-alpha modulators, syntheses of said modulators and methods of using said modulators
11/02/2005EP1591117A1 Breast cancer resistance protein (bcrp) inhibitor
11/02/2005EP1591112A1 Breast cancer-resistant protein inhibitor
11/02/2005EP1591020A1 Compositions containing coenzyme q10
11/02/2005EP1590434A2 Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods
11/02/2005EP1590372A2 Trimeric polypeptide construct to induce an enduring t cell response
11/02/2005EP1590360A1 Process for preparing inhibitors of nucleoside phosphorylases and nucleosidases
11/02/2005EP1590355A1 Novel tricyclic azepine derivatives, method for production therof and pharmaceutical compositions comprising the same
11/02/2005EP1590352A1 4-AMINOTHIENO [2,3-d] PYRIMIDINE-6-CARBONITRILE DERIVATIVES AS PDE7 INHIBITORS
11/02/2005EP1590348A1 Aryl / hetaryl substituted imidazoquinolines
11/02/2005EP1590347A1 Isothiazole derivatives
11/02/2005EP1590340A1 Inhibitors of histone deacetylase
11/02/2005EP1590328A2 (2-carboxamido) (3-amino) thiophene compounds
11/02/2005EP1590321A2 Aryl alkyl carbamate derivatives production and use thereof in therapy
11/02/2005EP1589998A2 Uses of mammalian cytokine; related reagents
11/02/2005EP1589997A2 Identification of cellular polypeptides differentially expressed by tumor cells
11/02/2005EP1589990A2 Method for treating cancer in humans
11/02/2005EP1589970A2 Pharmaceutical compositions comprising thieno [2,3-c]pyridine deritives and use thereof
11/02/2005EP1589967A1 Benzthiazole-3 oxides useful for the treatment of proliferative disorders
11/02/2005EP1507758B1 Indole derivatives and their use as ligands for cb2 receptors
11/02/2005EP1507530B1 Diaminothiazoles and use thereof as cdk4 inhibitors
11/02/2005EP1501833B1 N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/02/2005EP1501525B1 Method for producing preparations rich in tocotrienol
11/02/2005EP1501515B1 Triaryl-oxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/02/2005EP1482796A4 Stable compositions comprising tezacitabine
11/02/2005EP1444261B1 Immunogenic alk (anaplastic lymphoma kinase) peptides
11/02/2005EP1421214A4 Amplified oncogenes and their involvement in cancer
11/02/2005EP1377569B1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use as cardiovascular preparations
11/02/2005EP1357930B1 Histidine-rich glycoprotein (hrgp) for inhibiting angiogenesis
11/02/2005EP1332149B1 Glycerophosphoinositol derivatives as modulators of cytosolic a2 phospholipase
11/02/2005EP1278719B1 Naphthamide neurokinin antagonists for use as medicaments
11/02/2005EP1268524B1 Binding peptides for carcinoembryonic antigen (cea)
11/02/2005EP1246826B1 Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them
11/02/2005EP1246807B1 Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines
11/02/2005EP1237902B1 Halogenated sulphamate-, phosphonate-, thiophosphonate-, sulphonate- and sulphonamide- compounds as inhibitors of steroid sulphatase
11/02/2005EP1200123B1 Diagnosis and treatment of neuroectodermal tumors
11/02/2005EP1159261B1 Antizyme modulators and their use
11/02/2005EP1083905B1 Medical use of a selective estrogen receptor modulator in combination with a sex steroide precursor
11/02/2005EP1080095B1 Modulators of protein tyrosine phosphatases (ptpases)
11/02/2005EP1067944B1 Combined preparation comprising monocyte derived cells and chemotherapy drugs for the treatment of neoplasic diseases or of infectious diseases
11/02/2005EP1049686B1 Intermediates and methods useful in the semisynthesis of paclitaxel and analogs
11/02/2005EP0994706B1 Compositions for administering taxanes orally to human patients and their use
11/02/2005EP0973540B1 Isolation and structural elucidation of the cytostatic linear and cyclo-depsipeptides dolastatin 16, dolastatin 17, and dolastatin 18
11/02/2005EP0929520B1 Indolinone combinatorial libraries and related products and methods for the treatment of disease
11/02/2005EP0778842B1 Mammalian telomerase
11/02/2005EP0738152B1 Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents
11/02/2005CN1692127A TACI antibodies and uses thereof
11/02/2005CN1692124A P53 binding T cell receptor molecules and uses thereof
11/02/2005CN1692120A Inhibitors of nucleoside phosphorylases and nucleosidases
11/02/2005CN1692110A New 3-(4-oxygen-4H-benzopyranyl-2-base)-(1H)-quinoline-4-ketone derivant, its preparing method and drug compositions containing them
11/02/2005CN1691958A Enos mutants useful for gene therapy
11/02/2005CN1691957A 蛋白酶抑制剂 Protease inhibitors
11/02/2005CN1691945A Use of rapamycin for inhibiting of cell death
11/02/2005CN1691943A Cancer treatment with go6976 and its related compounds
11/02/2005CN1691941A Product comprising mikanolide, dihydromikanolide or an analogue thereof combine with another anti-cancer agent for therapeutic use in cancer treatment
11/02/2005CN1690073A Steroid derivatives
11/02/2005CN1689646A Combination therapies for B-cell lynphomas comprising administration of anti-CD20 antibody
11/02/2005CN1689645A Combination therapies for B-cell lynphomas comprising administration of anti-CD20 antibody
11/02/2005CN1689644A Combination therapies for B-cell lynphomas comprising administration of anti-CD20 antibody
11/02/2005CN1225481C Recombinant fusion resisting tumour attack and transfer
11/02/2005CN1225476C Human cervical cancer 1 protooncogene and protein encoded therein
11/02/2005CN1225469C Di (N-chlorolactamic acid) potassium platinate, its preparation method and its application
11/02/2005CN1225286C Short interference ribonucleic acid as novel anti-tumor gene therapeutic medicine
1 ... 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 ... 2211